Immatics at SITC (Nov 7-11) in Washington, DC
We're happy to announce, that Immatics will be part of the SITC Conference in Washington, DC (Nov 7-11). If you're there, stop by and discuss with our experts newest trial results and scientific insights:
November 10th, 12:20pm-1:50pm and 7:00pm-8:30pm
Poster: "The GAPVAC approach of actively personalized peptide vaccination for patients with newly diagnosed glioblastoma." (Abstract Poster #O8)
Presenter: Norbert Hilf (Vice President Translational Development)
Poster: "Targeting novel tumor-associated antigens with TCR-engineered T Cells" (Abstract Poster #P246)
Presenter: Mamta Kalra (Associate Director CMC, Immatics US)
In addition, the GAPVAC approach will also be presented in a talk by Hideho Okada (UCSF):
November 9th, 3:00pm-3:15pm
"The GAPVAC approach of actively personalized peptide vaccination for patients with newly diagnosed glioblastoma"
Speaker: Hideho Okada (University of California, San Francisco, USA and Parker Institute for Cancer Immunotherapy)
Session: "Early Phase 1 Clinical Trials"
We're looking forward to interesting and exciting discussions.
Further information about SITC here.
Further information about GAPVAC here.